Singapore-based The Sylvan Group, backed by members of the Hyundai and Rockefeller families, said on Wednesday that it had bought majority stakes in four Singapore healthcare and pharmaceutical firms for $140.5 million.
Kyungsun Chung, co-founder and a managing partner of Sylvan, an impact investor, said in a statement the investments were made from its Sylvan Asia Growth Fund I, which has already raised about half of its targeted $400 million from investors.
